![Frédéric Fasano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Fasano
Directeur/Membre du Conseil chez
Acesis Holdings Corp.
Profil
Frédéric Fasano is currently a Director at the Institute of Corporate Directors, National Pharmaceutical Association, and Acesis Holdings Corp.
He was previously the President & Chief Executive Officer at Servier Canada, Inc. from 2006 to 2020.
He also served as the Chairman at Innovative Medicines Canada from 2017 to 2020 and as a Director at ILKOS THERAPEUTICS, Inc. from 2016 to 2020.
Mr. Fasano holds an MBA from ESSEC Business School and a doctorate from Université Paris-Saclay.
Postes actifs de Frédéric Fasano
| Sociétés | Poste | Début |
|---|---|---|
Acesis Holdings Corp.
 Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Directeur/Membre du Conseil | - |
National Pharmaceutical Association
 National Pharmaceutical Association Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Association is a company based in Phoenix. | Directeur/Membre du Conseil | - |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Directeur/Membre du Conseil | - |
Anciens postes connus de Frédéric Fasano
| Sociétés | Poste | Fin |
|---|---|---|
| VALEO PHARMA INC. | President | 21/11/2022 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Directeur/Membre du Conseil | 01/12/2020 |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Directeur Général | 01/11/2020 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Président | 01/11/2020 |
Formation de Frédéric Fasano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Servier Canada, Inc.
Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Commercial Services |
Valeo Pharma, Inc.
 Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Pharmaceutical Association
National Pharmaceutical Association Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Association is a company based in Phoenix. | Commercial Services |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Health Technology |
